Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study [Phase 4]
Phase 4 clinical trial update evaluating cardiovascular effects of systolic blood pressure control in hypertension.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Accuracy of Non-invasive Non-oscillometric Blood Pressure Wristband [NA]
Clinical trial update on the accuracy of a non-invasive wristband for measuring blood pressure; completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension . [Phase 4]
Phase 4 clinical trial assessing sildenafil (Viagra) for efficacy and safety in subjects with arterial hypertension and impotence; completed…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients [Phase 4]
Phase 4 trial update evaluating doxazosin GI therapeutic system on ambulatory blood pressure and cardiovascular risk factors in uncontrolled…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Amlodipine Diabetic Hypertension Efficacy Response Trial [Phase 4]
Phase 4 clinical trial update for amlodipine in hypertension; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels [Phase 3]
Phase 3 trial evaluating an amlodipine/atorvastatin combination to reduce health risks from hypertension and hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia [Phase 3]
Open-label phase 3 trial evaluating the combination of amlodipine and atorvastatin in subjects with hypertension and dyslipidemia has comple…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population [Phase 4]
Phase 4 trial update evaluating Caduet's ability to achieve blood pressure and lipid endpoints in adults with hypertension and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Caduet in an Untreated Subject Population [Phase 4]
Phase 4 trial update for Caduet in untreated subjects showing completed status.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Cardiovascular Risk Assessment in Patients Treated With Caduet [Phase 4]
Phase 4 trial update evaluating cardiovascular risk assessment in patients treated with Caduet.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia [Phase 4]
Phase 4 trial comparing co-administration of amlodipine/atorvastatin versus amlodipine alone in patients with hypertension and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. [Phase 4]
Open-label Phase 4 trial evaluating the effectiveness of an amlodipine-atorvastatin combination for hypertension and hyperlipidemia; complet…
-
FDA approval · 2021-01-27FDA Approved: FUROSEMIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a new generic version of furosemide from Sagent Pharmaceuticals under an original application, enabling market entry as a loop …
-
FDA approval · 2021-01-25FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for olmesartan medoxomil and hydrochlorothiazide, a combination antihypertensive product from Aurobi…
-
FDA approval · 2021-01-25FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lifestar Pharma LLC)
The FDA approved a supplemental application for the combination drug olmesartan medoxomil and hydrochlorothiazide manufactured by Lifestar P…
-
FDA approval · 2021-01-21FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application to market a generic fixed-dose combination of olmesartan medoxomil and hy…
-
FDA approval · 2021-01-21FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for the combination product olmesartan medoxomil and hydrochlorothiazide from Accord Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan [Phase 3]
Phase 3 trial update assessing the combined Rosuvastatin/Ezetimibe with Telmisartan for hypercholesterolemia and hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk [Phase 4]
Phase 4 trial assessing the effect of rosuvastatin on coronary flow reserve in hypertensive patients at cardiovascular risk has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis [Phase 3]
Phase 3 clinical trial update evaluating ACE inhibitors in patients on hemodialysis for left ventricular hypertrophy and hypertension has co…
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Retail Outlet Health Kiosk Hypertension Trial [NA]
A completed clinical trial on a retail outlet health kiosk for hypertension with results posted in 2021.
-
FDA approval · 2021-01-07FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) [Phase 4]
Phase 4 clinical trial update for BRAVE Study in uncontrolled essential hypertension completed.
-
FDA approval · 2021-01-04FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for the fixed-dose combination product amlodipine and olmesartan medoxomil from Macleods Pharmac…
-
FDA approval · 2021-01-04FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for a fixed-dose combination tablet of amlodipine and olmesartan medoxomil for hyperten…